Terray Therapeutics key facts
- Operator of an Artificial Intelligence driven biotechnology company intended to provide advanced machine learning and AI models to speed drug discovery and development.
- It has raised $226.3M.
- Notable investors include Mana Ventures, Alexandria Venture Investments, Madrona Venture Group, NVentures (Santa Clara), Two Sigma Ventures — 20 tracked in total.
- Status: Privately Held (backing).
Who backs Terray Therapeutics
20+- ·The complete investor list: 20 names
- ·Watch Terray Therapeutics: the Monday email on marks, rounds and moves
Terray Therapeutics funding rounds
No funding rounds for Terray Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Terray Therapeutics investors
20 investors are on record for Terray Therapeutics, including Mana Ventures, Alexandria Venture Investments, Madrona Venture Group and NVentures (Santa Clara). By type, the record holds 8 venture capital firms, 1 hedge fund and 1 asset manager.
About Terray Therapeutics
Operator of an Artificial Intelligence driven biotechnology company intended to provide advanced machine learning and AI models to speed drug discovery and development. The company's internal pipeline is focused on developing small-molecule drugs in immunology, by use of artificial intelligence, synthetic chemistry, automation, and nanotechnology to generate the chemical datasets using ultra-dense microarray technology that works seamlessly with the integrated machine learning and computational platform to systematically map biochemical interactions between small molecules and causes of disease and iterative cycles of virtual molecular design and experimentation power AI and machine learning models that in turn guide the next cycle of design, enabling doctors to derive insights to predict and create drugs for patients in need.
- Sector
- Healthcare
- HQ
- Monrovia, CA, United States
- Founded
- 2018
- Employees
- 122
- Website
- terraytx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Terray Therapeutics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.